Pepsigard T Tablet

Introduction

Pepsigard T is a prescription medication that contains Sucralfate as its active ingredient. It is available in tablet form and is commonly known by its generic name.

Uses

Pepsigard T is primarily prescribed for the treatment of certain gastrointestinal conditions, including gastric and duodenal ulcers. It forms a protective layer over the ulcers, allowing them to heal and preventing further irritation.

Dosage and Administration

The dosage of Pepsigard T may vary depending on the individual’s condition and medical history. Follow the instructions provided by your healthcare professional. Generally, the recommended dose for adults is 1 tablet four times a day, taken on an empty stomach at least 1 hour before meals or at bedtime.

Mechanism of Action

Sucralfate, the active ingredient in Pepsigard T, works by binding to the surface of ulcers in the gastrointestinal tract, forming a protective barrier. This barrier shields the ulcers from stomach acid, bile salts, and enzymes, allowing them to heal. Additionally, Sucralfate may enhance the production of prostaglandins, which are natural substances that promote healing and protect the stomach lining.

Side Effects

Common side effects may include constipation, nausea, vomiting, and stomach discomfort. These side effects are usually mild and temporary. However, if any of these side effects persist or worsen, consult your healthcare professional.

In rare cases, Pepsigard T may cause more serious side effects such as allergic reactions (e.g., rash, itching, swelling), difficulty breathing, and severe stomach pain. If you experience any of these serious side effects, seek immediate medical attention.

Drug Interactions

inform your healthcare professional about all the medications you are taking, including prescription and over-the-counter medications, vitamins, and herbal supplements. Certain medications may interact with Pepsigard T, potentially affecting its effectiveness or increasing the risk of side effects. Common drug interactions may include antacids, fluoroquinolone antibiotics, and digoxin. Your healthcare professional will be able to provide specific guidance on potential drug interactions.

Precautions

Before taking Pepsigard T, inform your healthcare professional about any allergies, medical conditions, or medications you are currently taking. This medication may not be suitable for everyone, and certain precautions should be taken. It is contraindicated in individuals with known hypersensitivity to Sucralfate or any of the tablet’s inactive ingredients.

Pepsigard T should be used with caution in individuals with kidney problems or those who are on dialysis. Note that Pepsigard T may interfere with the absorption of other medications. Therefore, it is recommended to take Pepsigard T at least 2 hours before or after other medications.

Storage

Patient Tips

• Take Pepsigard T as directed by your healthcare professional. Do not exceed the recommended dosage or duration of treatment.
• take Pepsigard T on an empty stomach, at least 1 hour before meals or at bedtime.
• If you are taking other medications, consult your healthcare professional to ensure there are no potential interactions with Pepsigard T.
• If you experience any unusual or persistent side effects, contact your healthcare professional.
• Store Pepsigard T in a cool, dry place and keep it out of reach of children.
• Follow up with your healthcare professional to monitor your progress and discuss any concerns or questions you may have.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Sucralfate (Drugs.com) [Accessed 6 Jun. 2024] (online) Available at:
• sucralfate (RX) [Accessed 16 Jun. 2024] (online) Available at:
• Sucralfate (MedlinePlus) [Accessed 25 Jun. 2024] (online) Available at:
• Abtahi-Naeini B, Saffaei A, Sabzghabaee AM, Amiri R, Hosseini NS, Niknami E, Dehghani S. Topical sucralfate for treatment of mucocutaneous conditions: A systematic review on clinical evidences. Dermatol Ther. 2022 Apr;35(4):e15334. doi: 10.1111/dth.15334. Epub 2022 Feb 7. [Accessed 8 Jun. 2024] Available at: